Introducing TCR App Mobility
TCR App Mobility is a Polish deep tech startup that builds unique datasets of digital biomarkers (focused on attention stability and high-dimensional health phenotyping) and develops proprietary ML models designed to analyse the driver's subconscious behavioural patterns — proudly classified among leading science-backed ventures from Central Europe.
We offer an autonomous medical diagnostic system (agentic AI) delivered to users via a SaMD-compliant mobile application. It can predict and prevent road traffic accidents caused by tiredness and inattention, achieving research-proven 94% effectiveness.
Our technology also enables prodromal, medical-grade diagnostics of neurological diseases (PD, AD, primary brain tumours) on the basis of subtle driving anomalies, currently focusing on the detection of Parkinson's disease approximately 5 years before the onset of clinical symptoms.
The Challenge
Our proprietary, foundational, medical-grade ML model — integrated into a SaMD-compliant mobile application — can prevent 94% of road accidents caused by tiredness and inattention within just 3 months of contact with a specific user. Globally, this category of accidents accounts for 25% of all road crashes, leading to over 5 million human injuries and more than €500 billion in financial losses per year. According to international statistics, traffic injuries are considered a dominant life-threatening factor for children and young adults (aged 5–29). They are particularly harmful to people with low income, citizens of developing countries and residents of rural areas.
TCR App Mobility contributes to the 3rd, 9th, 10th and 11th UN Development Goals, explicitly responding to the target no. 3.6 of the 3rd UN SDG (prevention of road traffic accidents and accompanying human injuries) and the target no. 11.2 of the 11th UN SDG (improving road safety, with special attention to the needs of those in the vulnerable situations).
Moreover, our algorithms are able to identify subtle changes in driving dynamics that are characteristic of prevalent neurodegenerative diseases (PD, AD) approximately 5 years before the onset of clinical symptoms — allowing the development and early start of disease-modifying therapies. As a consequence, we provide an empirically-proven and highly scalable solution to the most critical challenges in the transport industry and precision medicine.
Find Out More
Become Our Partner
Our startup offers multiple collaboration opportunities for corporate partners from automotive, transport, mobility, logistics, healthcare, insurance, travel and safety industries. The key areas we focus on include the commercial implementation of our solution, conducting pilots with partnering entities, participation in scientific research (testing new probabilistic models), data collection and analysis, as well as joint promotional activities. Our fundamental intention is to bring TCR App Mobility to developing countries, underprivileged communities, rural areas and individuals with low income — reducing social inequalities and contributing to the more equitable future of those who typically cannot afford to cover the costs of private insurance or healthcare.